ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : OSI Pharmaceuticals

Include trials that are no longer recruiting patients.

4 studies were found.
1.RecruitingErlotinib in Patients with Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small Cell Lung
2.RecruitingErlotinib in Treating Patients with Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
3.RecruitingErlotinib vs. Standard Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer and an Eastern Cooperative Oncology Group Performance Status of 2
Condition: Non-Small Cell Lung Carcinoma
4.Not yet recruitingOSI-7904L versus 5-FU/LV as Treatment in Patients with Biliary Tract Cancer
Condition: Bilary Tract Cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act